ID

42742

Descripción

Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01536028

Link

https://clinicaltrials.gov/show/NCT01536028

Palabras clave

Versiones (2)
  1. 16/3/17 16/3/17 -
  2. 17/9/21 17/9/21 -
Subido en

17 de septiembre de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes NCT01536028

Inglés

Eligibility Diabetes NCT01536028

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01536028
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 1 diabetes for at least 12 months
Descripción

Insulin-Dependent Diabetes Mellitus disease length

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011854
UMLS CUI [1,2]
C0872146
serum c-peptide maximum 0.4 ng/ml
Descripción

C-peptide Maximum

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0006558
UMLS CUI [1,2]
C0806909
current basal bolus treatment with soluble human insulin, insulin lispro, insulin glulisine, nph insulin, insulin detemir or insulin glargine
Descripción

Therapeutic procedure Bolus Basis | Insulin soluble human | Insulin Lispro | Insulin, Glulisine | insulin, isophane | insulin detemir | Insulin Glargine

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C1705509
UMLS CUI [1,3]
C1527178
UMLS CUI [2]
C0795635
UMLS CUI [3]
C0293359
UMLS CUI [4]
C1313386
UMLS CUI [5]
C0021658
UMLS CUI [6]
C0537270
UMLS CUI [7]
C0907402
bmi (body mass index) maximum 32 kg/m^2
Descripción

Body mass index

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
hba1c (glycosylated haemoglobin) maximum 9% based on analysis from central laboratory
Descripción

Glycosylated hemoglobin A Percentage Maximum

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019018
UMLS CUI [1,2]
C0439165
UMLS CUI [1,3]
C0806909
non-smoker
Descripción

Non-smoker

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0337672
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
the receipt of any investigational drug within the last 30 days prior to this trial
Descripción

Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013230
total daily insulin dose at least 1.8 u/kg/day
Descripción

Insulin Cumulative Dose U/day

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C2986497
UMLS CUI [1,3]
C0456683
current treatment with iasp (insulin aspart) products
Descripción

Insulin Aspart

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1708521
a history of drug or alcohol abuse within the last 5 years
Descripción

Substance Use Disorders

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038586
impaired hepatic function
Descripción

Liver Dysfunction

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0086565
impaired renal function
Descripción

Renal Insufficiency

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1565489
cardiac problems
Descripción

cardiac problem

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0262402
severe, uncontrolled hypertension
Descripción

Uncontrolled hypertension Severe

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1868885
UMLS CUI [1,2]
C0205082
Volver a la parte superior de la página

Similar models

Eligibility Diabetes NCT01536028

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01536028
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Insulin-Dependent Diabetes Mellitus disease length
Item
type 1 diabetes for at least 12 months
boolean
C0011854 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C-peptide Maximum
Item
serum c-peptide maximum 0.4 ng/ml
boolean
C0006558 (UMLS CUI [1,1])
C0806909 (UMLS CUI [1,2])
Therapeutic procedure Bolus Basis | Insulin soluble human | Insulin Lispro | Insulin, Glulisine | insulin, isophane | insulin detemir | Insulin Glargine
Item
current basal bolus treatment with soluble human insulin, insulin lispro, insulin glulisine, nph insulin, insulin detemir or insulin glargine
boolean
C0087111 (UMLS CUI [1,1])
C1705509 (UMLS CUI [1,2])
C1527178 (UMLS CUI [1,3])
C0795635 (UMLS CUI [2])
C0293359 (UMLS CUI [3])
C1313386 (UMLS CUI [4])
C0021658 (UMLS CUI [5])
C0537270 (UMLS CUI [6])
C0907402 (UMLS CUI [7])
Body mass index
Item
bmi (body mass index) maximum 32 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Glycosylated hemoglobin A Percentage Maximum
Item
hba1c (glycosylated haemoglobin) maximum 9% based on analysis from central laboratory
boolean
C0019018 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0806909 (UMLS CUI [1,3])
Non-smoker
Item
non-smoker
boolean
C0337672 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Investigational New Drugs
Item
the receipt of any investigational drug within the last 30 days prior to this trial
boolean
C0013230 (UMLS CUI [1])
Insulin Cumulative Dose U/day
Item
total daily insulin dose at least 1.8 u/kg/day
boolean
C0021641 (UMLS CUI [1,1])
C2986497 (UMLS CUI [1,2])
C0456683 (UMLS CUI [1,3])
Insulin Aspart
Item
current treatment with iasp (insulin aspart) products
boolean
C1708521 (UMLS CUI [1])
Substance Use Disorders
Item
a history of drug or alcohol abuse within the last 5 years
boolean
C0038586 (UMLS CUI [1])
Liver Dysfunction
Item
impaired hepatic function
boolean
C0086565 (UMLS CUI [1])
Renal Insufficiency
Item
impaired renal function
boolean
C1565489 (UMLS CUI [1])
cardiac problem
Item
cardiac problems
boolean
C0262402 (UMLS CUI [1])
Uncontrolled hypertension Severe
Item
severe, uncontrolled hypertension
boolean
C1868885 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial